Click on image to view larger version.

Figure 2 Results of Kaplan-Meier analysis showing cardiovascular (CV) death-free survival in the high-risk patients divided by the T^–786C endothelial nitric oxide synthase (eNOS) genotype. The TT homozygous patients had a significantly lower CV death-free survival.